COMBINATION THERAPY FOR HEPATOCELLULAR CARCINOMA: A SYSTEMS BIOLOGY PERSPECTIVE ON THE SYNERGISTIC ANTITUMOR ACTIVITY OF SORAFENIB WITH PI3K/AKT PATHWAY INHIBITORS
50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, Vienna, Austria, 22 - 26 April 2015, vol.62, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- Volume: 62
- Doi Number: 10.1016/s0168-8278(15)30614-0
- City: Vienna
- Country: Austria
- Middle East Technical University Affiliated: Yes